Conference Program
ADIT 2018 Program planners and contributors:
Prof. Geremia B. Bolli, Dr. Matthew D. Campbell, Prof. Andrej Janez, Prof. Juris J. Meier, Prof. Lea Smircic Duvnjak, Prof. Hannele Yki Jarvinen
Sunday, April 15
11.30 - 12.00 Welcome Lunch
12.00 - 12.25 10th Anniversary: ADIT Opening I Lalic N., Metelko Z.
Opening Lecture I Janez A.
12.25 - 13.25 Diabetes and Cancer I Janez A.
Links between Cancer, Obesity, and Diabetes I Grunberger G.
Management of diabetes in patient with cancer I Chowdhury T.
13.25 - 13.30 Break
13.30 - 15.00 Diabetes and Heart I Yki Jarvinen H.
Diagnosis and treatment of heart disease in diabetes I Lotan C.
Treatment of thrombosis in patient with Diabetes & Case Q&A I Lassila R.
15.00 - 15.05 Break
15.05 - 16.05 CVOTs what did we learn so far? I Lalic N.
Endpoints of recent CVOTs I Schernthaner G.
CVOTs - Critical review I Meier J.J.
16.05 - 16.15 Break
16.15 - 17.15 Diabetes - liver - gut: connection that matters? I Taylor R.
Advanced fibrosis in patient with Diabetes I Yki Jarvinen H.
The Gut: A Key to the Pathogenesis of Type 2 Diabetes? I Knop F.K.
17.15 - 17.30 Coffee Break
17.30 - 19.00 Industry sponsored Session
20.00- 22.00 Opening Ceremony & Reception
Monday, April 16
8.00 - 9.00 Industry sponsored Session
9.15 - 10.35 Optimization of Insulin therapy: Where to start? I Bolli G.
Overcoming Barriers to insulin therapy I Pouwer F.
T2DM: old tricks - new insulins or both I Yki Jarvinen H.
Insulin delivery methods: past present future I Kesavadev J.
10.35 - 10.45 Coffee Break
10.45 - 11.45 Injectable therapy in T2DM inadequately Controlled on Oral Agents: Fixed - dose or flexible combination? I Knop F.K.
Flexible dose combinations I Bolli G.
Fixed-dose combinatons I Standl E.
11.45 - 11.50 Break
11.50 - 12.20 ADIT 2018 Best Abstracts I Yki Jarvinen H.
Islet Autoantibodies Measurement and Genetic Testing I Pape Medvidovic E.
Long-term outcomes of bone-marrow mononuclear cell therapy, percutaneous angioplasty and conservative therapy in diabetic patients with critical limb ischemia I Nemcova A.
Efficacy and safety of patient - versus physician-managed titration of insulin I Smircic Duvnjak L.
12.20 - 13.10 Lunch
13.10 - 14.10 Lifestyle modifications: reversal and prevention of T2DM I Mitrakou Fanariotou A.
Intensive LM for the prevention of T2DM I Campbell M.D.
Reversal of T2DM: An update of the DiRECT trial I Taylor R.
14.10 - 14.15 Break
14.15 - 15.45 Challenging patient Cases I Tesfaye S.
Obese patient with Type 2 diabetes and severe insulin resistance I Meier J.J.
Case: CKD in T1DM patient I Karalliedde J.
T2DM management in the elderly patient I Schernthaner G.
15.45 - 15.55 Break
15.55 - 17.15 ADIT Forum : Evidence based medicine: What is it and are we there yet? I Grunberger G.
I Bolli G.
Forum discussion I Bosnyak Z.
I Standl E.
17.30 - 19.00 Industry sponsored Session
Tuesday, April 17
8.30 - 9.30 Microvascular complications: Retinopathy I Broz J., Veresiu I.
Plasticity of the Retinal Microvasculature I Tapp R.
Case presentation I Summanen P.
9.30 - 9.35 Break
9.35 - 10.35 How to balance efficacy and safety of new glucose lowering drugs? I Meier J.J.
SGLT2 I Smircic Duvnjak L.
Incretin based therapies (GLP-1 and DPP4) I Deacon C.F.
10.35 - 10.45 Coffee Break
10.45 - 11.45 Diabetic neuropathy and Diabetic foot I Standl S.
Treatment pathway for painful diabetic neuropathy I Tesfaye S.
Interactive case presentation: Diabetic ulcers I Meier J.J.
11.45 - 11.50 Break
11.50 - 12.50 T1DM: good to know I Bolli G.
Implications for Double Diabetes and CV Risk Reduction in T1DM I Campbell M.D.
Exercise and Physical Activity in Type 1 Diabetes I Yardley J.
13.00 - 13.45 Farewell Lunch